Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Chronic high Epstein-Barr viral load state and risk for late-onset posttransplant lymphoproliferative disease/lymphoma in children.

Bingler MA, Feingold B, Miller SA, Quivers E, Michaels MG, Green M, Wadowsky RM, Rowe DT, Webber SA.

Am J Transplant. 2008 Feb;8(2):442-5. doi: 10.1111/j.1600-6143.2007.02080.x.

2.

Ratio between Epstein-Barr viral load and anti-Epstein-Barr virus specific T-cell response as a predictive marker of posttransplant lymphoproliferative disease.

Smets F, Latinne D, Bazin H, Reding R, Otte JB, Buts JP, Sokal EM.

Transplantation. 2002 May 27;73(10):1603-10.

PMID:
12042647
3.

Predictive negative value of persistent low Epstein-Barr virus viral load after intestinal transplantation in children.

Green M, Bueno J, Rowe D, Mazariegos G, Qu L, Abu-Almagd K, Reyes J.

Transplantation. 2000 Aug 27;70(4):593-6.

PMID:
10972215
4.

Serial measurement of Epstein-Barr viral load in peripheral blood in pediatric liver transplant recipients during treatment for posttransplant lymphoproliferative disease.

Green M, Cacciarelli TV, Mazariegos GV, Sigurdsson L, Qu L, Rowe DT, Reyes J.

Transplantation. 1998 Dec 27;66(12):1641-4.

PMID:
9884252
5.

Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction.

Omar H, Hägglund H, Gustafsson-Jernberg A, LeBlanc K, Mattsson J, Remberger M, Ringdén O, Sparrelid E, Sundin M, Winiarski J, Yun Z, Ljungman P.

Transpl Infect Dis. 2009 Oct;11(5):393-9. doi: 10.1111/j.1399-3062.2009.00410.x. Epub 2009 May 26.

PMID:
19497070
6.

Evaluation of use of Epstein-Barr viral load in patients after allogeneic stem cell transplantation to diagnose and monitor posttransplant lymphoproliferative disease.

Gärtner BC, Schäfer H, Marggraff K, Eisele G, Schäfer M, Dilloo D, Roemer K, Laws HJ, Sester M, Sester U, Einsele H, Mueller-Lantzsch N.

J Clin Microbiol. 2002 Feb;40(2):351-8. Erratum in: J Clin Microbiol 2002 Jun;40(6):2316.

7.

Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients.

Stevens SJ, Verschuuren EA, Pronk I, van Der Bij W, Harmsen MC, The TH, Meijer CJ, van Den Brule AJ, Middeldorp JM.

Blood. 2001 Mar 1;97(5):1165-71.

8.

Epstein Barr viral load monitoring by quantitative PCR in renal transplant patients.

Merlino C, Cavallo R, Bergallo M, Giacchino F, Bollero C, Negro Ponzi A, Cavallo G.

New Microbiol. 2003 Apr;26(2):141-9.

PMID:
12737195
9.

Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.

Schubert S, Renner C, Hammer M, Abdul-Khaliq H, Lehmkuhl HB, Berger F, Hetzer R, Reinke P.

J Heart Lung Transplant. 2008 Jan;27(1):100-5. doi: 10.1016/j.healun.2007.09.027.

PMID:
18187094
10.

Comparison of six different specimen types for Epstein-Barr viral load quantification in peripheral blood of pediatric patients after heart transplantation or after allogeneic hematopoietic stem cell transplantation.

Ruf S, Behnke-Hall K, Gruhn B, Bauer J, Horn M, Beck J, Reiter A, Wagner HJ.

J Clin Virol. 2012 Mar;53(3):186-94. doi: 10.1016/j.jcv.2011.11.010. Epub 2011 Dec 17.

PMID:
22182950
11.

Epstein-Barr virus load in transplant patients: Early detection of post-transplant lymphoproliferative disorders.

Fellner MD, Durand KA, Solernou V, Bosaleh A, Balbarrey Z, García de Dávila MT, Rodríguez M, Irazu L, Alonio LV, Picconi MA.

Rev Argent Microbiol. 2016 Apr-Jun;48(2):110-8. doi: 10.1016/j.ram.2016.02.006. Epub 2016 May 4.

13.

Quantitative Epstein-Barr virus viral load monitoring in pediatric liver transplantation.

Jang JY, Kim KM, Lee YJ, Lee SG, Chi HS.

Transplant Proc. 2008 Oct;40(8):2546-8. doi: 10.1016/j.transproceed.2008.07.014.

PMID:
18929796
14.

[Epstein Barr viral load monitoring in mononuclear lymphocytes and serum of renal transplant recipients using a quantitative PCR protocol].

Merlino C, Giacchino F, Bergallo M, Bonello F, Bollero C, Segoloni GP, Cavallo R.

G Ital Nefrol. 2003 Mar-Apr;20(2):170-5. Italian.

PMID:
12746803
15.

The value of prospective monitoring of Epstein-Barr virus DNA in blood samples of pediatric liver transplant recipients.

Scheenstra R, Verschuuren EA, de Haan A, Slooff MJ, The TH, Bijleveld CM, Verkade HJ.

Transpl Infect Dis. 2004 Mar;6(1):15-22.

PMID:
15225222
16.

Epstein-Barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical course.

Oertel S, Trappe RU, Zeidler K, Babel N, Reinke P, Hummel M, Jonas S, Papp-Vary M, Subklewe M, Dörken B, Riess H, Gärtner B.

Ann Hematol. 2006 Jul;85(7):478-84. Epub 2006 Apr 4.

PMID:
16586109
17.
18.

Response to rituximab-based therapy and risk factor analysis in Epstein Barr Virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.

Styczynski J, Gil L, Tridello G, Ljungman P, Donnelly JP, van der Velden W, Omar H, Martino R, Halkes C, Faraci M, Theunissen K, Kalwak K, Hubacek P, Sica S, Nozzoli C, Fagioli F, Matthes S, Diaz MA, Migliavacca M, Balduzzi A, Tomaszewska A, Camara Rde L, van Biezen A, Hoek J, Iacobelli S, Einsele H, Cesaro S; Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.

Clin Infect Dis. 2013 Sep;57(6):794-802. doi: 10.1093/cid/cit391. Epub 2013 Jun 13.

PMID:
23771985
19.

Use of cytokine polymorphisms and Epstein-Barr virus viral load to predict development of post-transplant lymphoproliferative disorder in paediatric liver transplant recipients.

Lee TC, Savoldo B, Barshes NR, Rooney CM, Heslop HE, Gee AP, Caldwell Y, Scott JD, Goss JA.

Clin Transplant. 2006 May-Jun;20(3):389-93.

PMID:
16824159
20.

Post-transplant lymphoproliferative disorders and Epstein-Barr virus DNAemia in a cohort of lung transplant recipients.

Baldanti F, Rognoni V, Cascina A, Oggionni T, Tinelli C, Meloni F.

Virol J. 2011 Sep 5;8:421. doi: 10.1186/1743-422X-8-421.

Supplemental Content

Support Center